The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani).
Pierfrancesco Franco(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Filippo Alongi(Ospedale Sacro Cuore Don Calabria), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Andrea Riccardo Filippi(University of Turin), Michele Fiore(University of Oxford), Alba Fiorentino(Ospedale Sacro Cuore Don Calabria), Stefano Vagge(Ospedale Policlinico San Martino), Tiziana Comito(Humanitas University), Agnese Cecconi(European Institute of Oncology), Valentina Pinzi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Alessio Bruni(University of Modena and Reggio Emilia), Pierluigi Bonomo(Azienda Ospedaliero-Universitaria Careggi), Dante Amelio, Silvia Chiesa(Agostino Gemelli University Polyclinic), Gianluca Mortellaro, Marco Trovò(Centro di Riferimento Oncologico), De Bari B, Daniela Greto(Azienda Ospedaliero-Universitaria Careggi)
Cited by 17
Related Papers
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
|European Urology|2021|110
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
|Radiation Oncology|2012|109
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98